PATH staff are meeting with fellow researchers and partners at the 2008 World Vaccine Congress, being held in Arlington, Virginia, from April 21 through 24. The congress features the latest developments in the vaccine industry.
Leaders in vaccine development, including Merck, GlaxoSmithKline, the Aeras TB Foundation, and the International AIDS Vaccine Initiative, among others, are attending.
PATH staff will work to identify and build new relationships for vaccine development, availability, and delivery. Staff attending are:
- Linda Nyari, director of commercialization and corporate partnerships.
- Mark Alderson, director of our pneumococcal project.
- Jeff Maisonneuve, scientific director of our pneumococcal project.
PATH collaborates with the private sector on projects aimed at providing lifesaving vaccines for the developing world. Why? Vaccines are one of the most cost-effective health interventions of all time. Because of vaccines, some diseases, like small pox, are no longer a threat to society. Others, like polio, are on the verge of elimination.
Posted April 21, 2008.